An increase in intravitreal silicone oil associated with bevacizumab prepared with insulin syringes was documented. Priming the syringe before injection was associated with a lower frequency of this complication. These findings suggest that physicians should counsel their patients on the risk of floaters with intravitreal bevacizumab preloaded in insulin syringes.
No takes yet. Share an insight, caveat, or question.
Khurana et al. (2017) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: